BE THE NEW

Outsourcing Manager, Clinical Operations

in a biotech company focused on the discovery, design and development of innovative peptide-based medicines


Would you like to be a key driver in establishing a successful and efficient collaboration with our CROs in phase 1-3 trials? Are you organized and a strong negotiator?

Then come and join our Clinical Operations Department and become our new CRO Outsourcing Manager.

As we are expanding our Outsourcing group, we are looking for a new Outsourcing Manager. You should have a background of minimum of 3 years relevant experience within Outsourcing Management, Legal Contract Management, Trial Management or Procurement.

As you will be interacting with multiple internal and external colleagues, you must also demonstrate a high level of interpersonal skills and negotiation abilities.

Our Clinical Operations department consist of around 20 engaged and professional colleagues. We work as one team and value an informal atmosphere with focus on knowledge sharing and excellence. We are responsible for driving forward the clinical project portfolio by setting up, overseeing, and reporting clinical trials in collaboration with our CROs.

At Zealand, Outsourcing Management plays a central role in the CRO selection and collaboration. Together with our Senior Outsourcing Manager, you will be responsible for supporting the trial teams in the collaborations with our CROs and contribute to a smooth and seamless conduct of our clinical trials. Your main success criteria will be to build strong, trust-based relations with internal stakeholders and with our CROs to the mutual benefit for both parties.

Since regular office presence is required, candidates should be based in either Denmark or Sweden.



Responsibilities

As Outsourcing Manager, you will be responsible for the following:

CRO selection process
CRO and Stakeholder Management
Candidate profile

Bonding to innovate ​
Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.​

Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.​

We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We are curious about each other’s knowledge and expertise. ​

We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Zealand Pharma is a place where everyone is heard and contributes to the success, we all want to experience.​

The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.​

Let’s bond and be bold ​
We offer a combined compensation package which includes a base salary, pension, bonus, and a possibility to join our employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities

To find out more about working at Zealand, visit https://www.zealandpharma.com/careers/zealand-as-a-workplace/

Interested? Please apply no later than April 30, 2024, or as soon as possible. The applications will be reviewed as they come in.

For further information, please contact Christina Sylvest at csylvest@zealandpharma.com or 5060 3890.

About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn or Twitter @ZealandPharma.